Adam et al, Ann Intern Med 2012 Aug 28: Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism: A Systematic Review.
Benavente et al, N Engl J Med. 2012;367:817–825: Effects of clopidogrel added to aspirin in patients with recent lacunar stroke
Boulouis et al, J Neurol Neurosurg Psychiatry. 2017 Oct 13.: jnnp-2017-316631. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
Camm et al, Eur Heart J. 2012 Aug 24, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Connolly et al, N Engl J Med 2009 Sep 17;361(12):1139-51, Dabigatran versus warfarin in patients with atrial fibrillation (RE-LY trial).
Connolly et al, N Engl J Med. 2011 Mar 3;364(9):806-17. Apixaban in patients with atrial fibrillation. (AVERROES)
Connolly et al, N Engl J Med. 2019 Apr 4;380(14):1326-1335. Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. (ANNEXA-4)
CURRENT– OASIS 7 Investigators, N Engl J Med 2010;363:930-42. Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
Diener et al, J Neurol Sci 1996;143:1-13, Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke (ESPS2)
Diener et al, Lancet, 364 (2004), pp. 331–337, Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients randomized, double-blind, placebo-controlled trial (MATCH)
Diener et al, N Engl J Med. 2019 May 16;380(20):1906-1917. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. (RE-SPECT ESUS)
Diener et al, Lancet Neurol 2010; 9: 1157–63, Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
Halkes et al, ESPRIT Study Group, Lancet 2006;367:1665–1673, Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin: a randomised controlled trial (ESPRIT).
Friberg et al, Open Heart 2017;4:e000682. doi:10.1136/openhrt-2017-000682 Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
Gorelick et al, Stroke Research and Treatment, Volume 2013, Article ID 727842 Review Article: Advances in Our Understanding of ‘‘Resistance’’ to Antiplatelet Agents for Prevention of Ischemic Stroke
Granger at al, N Engl J Med 2011 Sep 15;365(11):981-92, Apixaban versus Warfarin in Patients with Atrial Fibrillation (ARISTOTLE trial)
Guigliano et al, N Engl J Med 2013 Nov 28;369(22):2093-104, Edoxaban versus warfarin in patients with atrial fibrillation (ENGAGE AF-TIMI 48 trial)
Halvorsen et al, Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):28-36. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
Hart et al, N Engl J Med. 2018 Jun 7;378(23):2191-2201, Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source (NAVI- GATE-ESUS trial)
Huang at al, JAMA Neurol. 2018 Dec 1;75(12):1511-1518. Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis.
Huhtakangas et al, Int J Stroke. 2015 Aug;10(6):876-81, Improved survival of patients with warfarin - associated intracerebral haemorrhage: a retrospective longitudinal population-based study
Johnston et al, N Engl J Med. 2016 Jul 7;375(1):35-43, Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack (SOCRATES trial)
Johnston et al, N Engl J Med. 2018 Jul 19;379(3):215-225, Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT trial)
Kermer et al, Int J Stroke. 2017 Jun;12(4):383-391, Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.
Kim et al, Stroke 2019 Dec;50(12):3503-3511, Cilostazol Mono and Combination Treatments in Ischemic Stroke: An Updated Systematic Review and Meta-Analysis,
Lee et al, Stroke 2017;48:2610–2613, Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin, A Systematic Review and Meta-Analysis
Ntaois et al, Stroke. 2017;48:2494-2503, Real-World Setting Comparison of Nonvitamin-K Antagonist
Olesen et al, Thrombosis and Hemostasis 2011: 106: 739-749, Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ’real world’ nationwide cohort study.
Parry-Jones et al, Ann Neurol. 2015 Jul;78(1):54-62, Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.
Patel et al, N Engl J Med 2011;365:883-91, Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (ROCKET-AF trial)
Pink et al, BMJ 2011, Oct 31; 343, Dabigatran etexilate versus warfarin in management of non-valvular at-rial fibrillation in UK context: quantitative benefit-harm and economic analyses
Pollack et al, N Engl J Med. 2017 Aug 3;377(5):431-441, Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. (RE-VERSE AD)
Reddy et al, J Am Coll Cardiol. 2017 Nov 4. pii: S0735-1097(17)41187-9, 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
Rothwell et al, Lancet. 2007 Oct 20;370(9596):1432-42, Effect of urgent treatment of transient ischaemic attack and minor stroke on early recur- rent stroke (EXPRESS study): a prospective population-based sequential comparison.
Sacco et al, N Engl J Med 2008 Sep 18;359(12):1238-51. Epub 2008 Aug 27, Aspirin and extended-release dipy-ridamole versus clopidogrel for recurrent stroke (PROFESS trial).
Saxena et al, The Cochrane Library 2008, Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack
Schulz, Maturitas. 2013 Nov;76(3):267-71. Drug treatments in the secondary prevention of ischaemic stroke.
Siegal et al, N Engl J Med. 2015 Dec 17;373(25):2413-24. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
Sjalander et al, Thromb Res. 2018 Jul;167:113-118. Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation.
Socialstyrelsen, Nationella riktlinjer for vård vid stroke 2018 Nationella riktlinjer för vård vid stroke - Socialstyrelsen
Staerk et al, J Intern Med. 2018 Jan;283(1):45-55. Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study.
Steiner et al, Lancet Neurol. 2016 May;15(6):566-73. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial.
Wallentin et al, Lancet 2010: 376: 975-83: Efficacy and safety of dabigatran compared with warfarin at different levels of international normalized ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
Wang et al, N Engl J Med 2013;369:11-19. Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE)
Webb, A.J., et al., Lancet, 2010. 375(9718): p. 906-15. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.
Wright et al, N Engl J Med. 2015 Nov 26;373(22):2103-16. A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
